您要查找的是不是：
- 對照組為39.2%(P<0.01)。After IBA, T-Bil, D-Bil and TBA decreased significantly (P<0.01).
- 改良組臨床癥狀復發(fā)7.4%,對照組為33.3%,二者有顯著(zhù)性差異(P<0.05);in the control group, the papillae appeared shrunken chink and the clinical recurrence rate was 33.3%25 ( P<0.05).
- 組to form
- 觀(guān)察組剖宮產(chǎn)率11.8%,對照組為26.9%,兩組比較差異有顯著(zhù)性意義(P<0.05)。(P<0.05) The rate of caesarean operation of observed group is 11.8%25,but the contnast group is 26.9%25. Their comparison showing very important significance. (p<0.05).
- 結果顯示:臨床有效率達84.21%,對照組為24.39%(P<0.01),早晚PEF顯著(zhù)增加。The results showed that the effective rate was 84. 2%25 compared to 24. 9%25 in the patients without inhaled BDP(P<0. 01).
- 藥物不良反應發(fā)生率治療組、對照組分別是 37.5%、34.2%。5%25 and 34.2%25 cases had the adverse reaction in the test and the control group respectively.
- 接受大扶康加rhGM CSF治療的患者有效率為 88 0% ,對照組為 6 9 6% (P <0 0 5 )。Response rates were 88.0%25 in patients who recevived diflucan plus rhGM CSF and the control patients were 69.6%25 ( P <0 05), It was significantly less for the degree of ANC recovered & the period of fungus cleaned in patientsd who received diflucan plus rhGM CSF.
- 外周血T1/2和曲線(xiàn)下面積(AUC)實(shí)驗組均明顯高于對照組,差異有顯著(zhù)性意義(P<0.01)。The elimination half-life(t1/2)and the area under curve(AUC)in peripheral blood of study group were significantly longer or larger than those of control group(P<0.01).
- A、B（秋季）、C（冬季）各組5日內的總發(fā)熱率分別為39.65%、15%和10.7%明顯高于各自的對照組。The FRs of Groups A, B(autumn groups)and C (winter group) in neonates 5 days after birth were 39.65%25, 15%25 and 0.7%25 respectively, much higher than those of their control groups.
- 虎紅染色 :實(shí)驗組為陽(yáng)性 ,對照組為陰性。Rose bangle staining was positive in the castrated group.
- 以妊高征為指征的剖宮產(chǎn)率口服 Vit E組為 6 .1% ,顯著(zhù)低于對照組 36 .4% ( P<0 .0 1)。The Caesarean birth of the women in experimental group was 6.1%25 while that of the control group was 36.4%25 ( P <0.01).
- 采用接種后24小時(shí)灌胃給藥，ETB-2A、ETB-2B、ETB-2C分別為39/kg/d、4.58/kg/d、6g/kg/d，對照組則以生理鹽水灌胃。The ETB-2 was given by drenching after being implanted 24 hours, while control groups were given saline water.
- 一年內40.0%患者出現排斥反應，而對照組為62.5%；The incidence rate of rejection episodes was 40%25 in ALG/AHTG and 62.5%25 in MP group.
- 谷丙轉氨酶、谷草轉氨酶和堿性磷酸酶活性,分別比對照組提高了13.39%(P<0.05)、14.16%(P<0.05)和12.14%(P<0.05);The activities of glutamic propylic transaminase(GPT),glutamic oxaolacetic transaminase(GOT) and alkaline phosphatase(ALP) in serums were increased by 13.39%25(P<0.05),14.16%25(P<0.05) and 12.14%25(P<0.05) respectively.
- 總手術(shù)產(chǎn)率觀(guān)察組為7.8%,對照組為13.1%(P<0.05)。The percentage of caesarean section in test group(7.8%25 ) is lower than that of control group(7.8%25 ).
- 治療組有效96例(71.1%),對照組為75例(58.6%),P<0.05;Ninty-six patients(71.7%25) obtained effective outcome in the LDC group,while only 75 cases(58.6%25) did so in the RDC group.
- AIS患者的小腦扁桃體平均位置明顯低于對照組(分別為枕骨大孔上0.9mm和2.9mm)。In AIS patients and healthy controls,the mean position of the cerebellar tonsil was 0.9 and 2.9 mm above the BO line,respectively.
- 顯效率為76.86%,對照組為52%,二者比較有顯著(zhù)性差異。The marked effective rate of HPRC was 76.86%25,while that of EDT was 52%25(P<0.05).
- 實(shí)驗組上臂緊張圍出現增加(+0.9cm),而對照組為-0.1cm。But we find the upper arm surround distance (contract) in WS is increase significant more (+0.9cm) but increased a little in PS (-0.1cm).
- 結果:觀(guān)察組總有效率為56.92%,對照組17.39%。The results were rated with TDS.
